Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

NCT01668784

Conditions
Adenocarcinoma, Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma, Carcinoma, +18 more
Locations
  • Local Institution - 0182 Fayetteville, Arkansas, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Local Institution - 0024 Los Angeles, California, United States
  • University Of Southern California Los Angeles, California, United States
View all 168 locations
View Trial Details
Completed

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

NCT01061411

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Academ Zienkenhuis Bij De University Amsterdam, Netherlands
  • VU University Medical Center Amsterdam, Netherlands
View Trial Details
Completed

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

NCT02071862

Conditions
Adenocarcinoma, Adenoma, Breast Diseases, +38 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

NCT01034631

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Providence Health System: Roy and Patricia Disney Family Cancer Center Burbank, California, United States
  • Compassionate Cancer Care Medical Group, Inc. Corona, California, United States
View all 108 locations
View Trial Details
Completed

An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma

NCT03029780

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Cancer Specialists of North FL Jacksonville, Florida, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Local Institution Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

NCT01664182

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details

Related conditions